OSE Immunotherapeutics SA (EPA:OSE)
France · Delayed Price · Currency is EUR 4.980
-0.040 (-0.80%)
At close: Jan 9, 2026
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €111.66 million as of January 9, 2026. Its market cap has decreased by -28.71% in one year.
Market Cap
111.66M
Enterprise Value
98.67M
Revenue
83.44M
Ranking
n/a
PE Ratio
3.41
Stock Price
€4.98
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has increased from 104.30M to 111.66M, an increase of 7.05%. That is a compound annual growth rate of 0.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 112.55M | -2.52% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.66B |
| Sanofi | 100.69B |
| Sartorius Stedim Biotech | 21.47B |
| bioMérieux | 13.42B |
| Eurofins Scientific SE | 12.18B |
| Ipsen | 10.40B |
| ABIVAX Société Anonyme | 8.53B |
| Virbac | 3.03B |